Correlation Between Geron and Telix Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Geron and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Geron and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Geron and Telix Pharmaceuticals Limited, you can compare the effects of market volatilities on Geron and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Geron with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Geron and Telix Pharmaceuticals.

Diversification Opportunities for Geron and Telix Pharmaceuticals

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Geron and Telix is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Geron and Telix Pharmaceuticals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and Geron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Geron are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of Geron i.e., Geron and Telix Pharmaceuticals go up and down completely randomly.

Pair Corralation between Geron and Telix Pharmaceuticals

Given the investment horizon of 90 days Geron is expected to under-perform the Telix Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Geron is 1.13 times less risky than Telix Pharmaceuticals. The stock trades about -0.06 of its potential returns per unit of risk. The Telix Pharmaceuticals Limited is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  1,452  in Telix Pharmaceuticals Limited on September 3, 2024 and sell it today you would earn a total of  98.00  from holding Telix Pharmaceuticals Limited or generate 6.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Geron  vs.  Telix Pharmaceuticals Limited

 Performance 
       Timeline  
Geron 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Geron has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Geron is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Telix Pharmaceuticals 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals Limited are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Telix Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Geron and Telix Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Geron and Telix Pharmaceuticals

The main advantage of trading using opposite Geron and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Geron position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.
The idea behind Geron and Telix Pharmaceuticals Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities